Even With Some Risks, Intuitive Surgical Will See Solid Growth in 2020
Intuitive Surgical (NASDAQ: ISRG) reported solid, if not unspectacular compared to medical technology peers, earnings and revenue growth for the fourth quarter and year on Jan. 23. While investors should pay close attention to future studies on the efficacy of robotic surgery, Intuitive is likely to keep producing good numbers this year.
The company is the leading manufacturer and servicer in the robotic surgery field. Despite its consistent sales growth and gains in procedure growth, a lack of consensus on the effectiveness of robotic surgery compared to conventional surgeries poses a risk to this growth stock.
Minimally invasive surgery, or laparoscopic surgery, has become more popular over the last few decades as it has proven to be as effective, if not more so, than open surgery. It's generally understood that using a robotic surgery system results in fewer complications, shorter recovery times, reduced costs, and better outcomes. This type of surgery is done via small incisions in the body through which tubes enter. Instruments and cameras are passed through the tubes while a surgeon uses the instruments to perform surgery while viewing transmitted images on a video monitor.
Source Fool.com
